127 related articles for article (PubMed ID: 12454206)
1. A common human SCN5A polymorphism modifies expression of an arrhythmia causing mutation.
Ye B; Valdivia CR; Ackerman MJ; Makielski JC
Physiol Genomics; 2003 Feb; 12(3):187-93. PubMed ID: 12454206
[TBL] [Abstract][Full Text] [Related]
2. A trafficking defective, Brugada syndrome-causing SCN5A mutation rescued by drugs.
Valdivia CR; Tester DJ; Rok BA; Porter CB; Munger TM; Jahangir A; Makielski JC; Ackerman MJ
Cardiovasc Res; 2004 Apr; 62(1):53-62. PubMed ID: 15023552
[TBL] [Abstract][Full Text] [Related]
3. Long-QT syndrome-related sodium channel mutations probed by the dynamic action potential clamp technique.
Berecki G; Zegers JG; Bhuiyan ZA; Verkerk AO; Wilders R; van Ginneken AC
J Physiol; 2006 Jan; 570(Pt 2):237-50. PubMed ID: 16254012
[TBL] [Abstract][Full Text] [Related]
4. A Brugada syndrome mutation (p.S216L) and its modulation by p.H558R polymorphism: standard and dynamic characterization.
Marangoni S; Di Resta C; Rocchetti M; Barile L; Rizzetto R; Summa A; Severi S; Sommariva E; Pappone C; Ferrari M; Benedetti S; Zaza A
Cardiovasc Res; 2011 Sep; 91(4):606-16. PubMed ID: 21705349
[TBL] [Abstract][Full Text] [Related]
5. A novel mutation L619F in the cardiac Na+ channel SCN5A associated with long-QT syndrome (LQT3): a role for the I-II linker in inactivation gating.
Wehrens XH; Rossenbacker T; Jongbloed RJ; Gewillig M; Heidbüchel H; Doevendans PA; Vos MA; Wellens HJ; Kass RS
Hum Mutat; 2003 May; 21(5):552. PubMed ID: 12673799
[TBL] [Abstract][Full Text] [Related]
6. A ubiquitous splice variant and a common polymorphism affect heterologous expression of recombinant human SCN5A heart sodium channels.
Makielski JC; Ye B; Valdivia CR; Pagel MD; Pu J; Tester DJ; Ackerman MJ
Circ Res; 2003 Oct; 93(9):821-8. PubMed ID: 14500339
[TBL] [Abstract][Full Text] [Related]
7. Novel Brugada syndrome-causing mutation in ion-conducting pore of cardiac Na+ channel does not affect ion selectivity properties.
Amin AS; Verkerk AO; Bhuiyan ZA; Wilde AA; Tan HL
Acta Physiol Scand; 2005 Dec; 185(4):291-301. PubMed ID: 16266370
[TBL] [Abstract][Full Text] [Related]
8. A novel SCN5A arrhythmia mutation, M1766L, with expression defect rescued by mexiletine.
Valdivia CR; Ackerman MJ; Tester DJ; Wada T; McCormack J; Ye B; Makielski JC
Cardiovasc Res; 2002 Aug; 55(2):279-89. PubMed ID: 12123767
[TBL] [Abstract][Full Text] [Related]
9. A common SCN5A polymorphism modulates the biophysical defects of SCN5A mutations.
Shinlapawittayatorn K; Du XX; Liu H; Ficker E; Kaufman ES; Deschênes I
Heart Rhythm; 2011 Mar; 8(3):455-62. PubMed ID: 21109022
[TBL] [Abstract][Full Text] [Related]
10. Mouse models of SCN5A-related cardiac arrhythmias.
Charpentier F; Bourgé A; Mérot J
Prog Biophys Mol Biol; 2008; 98(2-3):230-7. PubMed ID: 19041666
[TBL] [Abstract][Full Text] [Related]
11. Intrinsic mechanism of the enhanced rate-dependent QT shortening in the R1623Q mutant of the LQT3 syndrome.
Oginosawa Y; Nagatomo T; Abe H; Makita N; Makielski JC; Nakashima Y
Cardiovasc Res; 2005 Jan; 65(1):138-47. PubMed ID: 15621041
[TBL] [Abstract][Full Text] [Related]
12. SCN5A channelopathies--an update on mutations and mechanisms.
Zimmer T; Surber R
Prog Biophys Mol Biol; 2008; 98(2-3):120-36. PubMed ID: 19027780
[TBL] [Abstract][Full Text] [Related]
13. Biophysical characterization of a new SCN5A mutation S1333Y in a SIDS infant linked to long QT syndrome.
Huang H; Millat G; Rodriguez-Lafrasse C; Rousson R; Kugener B; Chevalier P; Chahine M
FEBS Lett; 2009 Mar; 583(5):890-6. PubMed ID: 19302788
[TBL] [Abstract][Full Text] [Related]
14. Substitution of a conserved alanine in the domain IIIS4-S5 linker of the cardiac sodium channel causes long QT syndrome.
Smits JP; Veldkamp MW; Bezzina CR; Bhuiyan ZA; Wedekind H; Schulze-Bahr E; Wilde AA
Cardiovasc Res; 2005 Aug; 67(3):459-66. PubMed ID: 16039271
[TBL] [Abstract][Full Text] [Related]
15. A novel SCN5A mutation associated with long QT-3: altered inactivation kinetics and channel dysfunction.
Rivolta I; Clancy CE; Tateyama M; Liu H; Priori SG; Kass RS
Physiol Genomics; 2002 Sep; 10(3):191-7. PubMed ID: 12209021
[TBL] [Abstract][Full Text] [Related]
16. New mechanism contributing to drug-induced arrhythmia: rescue of a misprocessed LQT3 mutant.
Liu K; Yang T; Viswanathan PC; Roden DM
Circulation; 2005 Nov; 112(21):3239-46. PubMed ID: 16301357
[TBL] [Abstract][Full Text] [Related]
17. Non-equilibrium gating in cardiac Na+ channels: an original mechanism of arrhythmia.
Clancy CE; Tateyama M; Liu H; Wehrens XH; Kass RS
Circulation; 2003 May; 107(17):2233-7. PubMed ID: 12695286
[TBL] [Abstract][Full Text] [Related]
18. A mutation in the human cardiac sodium channel (E161K) contributes to sick sinus syndrome, conduction disease and Brugada syndrome in two families.
Smits JP; Koopmann TT; Wilders R; Veldkamp MW; Opthof T; Bhuiyan ZA; Mannens MM; Balser JR; Tan HL; Bezzina CR; Wilde AA
J Mol Cell Cardiol; 2005 Jun; 38(6):969-81. PubMed ID: 15910881
[TBL] [Abstract][Full Text] [Related]
19. Overlap syndrome of cardiac sodium channel disease in mice carrying the equivalent mutation of human SCN5A-1795insD.
Remme CA; Verkerk AO; Nuyens D; van Ginneken AC; van Brunschot S; Belterman CN; Wilders R; van Roon MA; Tan HL; Wilde AA; Carmeliet P; de Bakker JM; Veldkamp MW; Bezzina CR
Circulation; 2006 Dec; 114(24):2584-94. PubMed ID: 17145985
[TBL] [Abstract][Full Text] [Related]
20. Biophysical phenotypes of SCN5A mutations causing long QT and Brugada syndromes.
Baroudi G; Chahine M
FEBS Lett; 2000 Dec; 487(2):224-8. PubMed ID: 11150514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
